BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 21926901)

  • 1. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.
    Ustaalioglu BO; Bilici A; Kefeli U; Şeker M; Oncel M; Gezen C; Gumus M; Demirelli F
    Am J Clin Oncol; 2012 Dec; 35(6):580-6. PubMed ID: 21926901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
    Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
    Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased lymph node positivity in multifocal and multicentric breast cancer.
    Cabioglu N; Ozmen V; Kaya H; Tuzlali S; Igci A; Muslumanoglu M; Kecer M; Dagoglu T
    J Am Coll Surg; 2009 Jan; 208(1):67-74. PubMed ID: 19228505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results: double lumpectomies for multicentric breast carcinoma.
    Kapoor NS; Chung A; Huynh K; Giuliano AE
    Am Surg; 2012 Dec; 78(12):1345-8. PubMed ID: 23265123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy.
    Ataseven B; Lederer B; Blohmer JU; Denkert C; Gerber B; Heil J; Kühn T; Kümmel S; Rezai M; Loibl S; von Minckwitz G
    Ann Surg Oncol; 2015 Apr; 22(4):1118-27. PubMed ID: 25297900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution.
    Gentilini O; Veronesi P; Botteri E; Soggiu F; Trifirò G; Lissidini G; Galimberti V; Musmeci S; Raviele PR; Toesca A; Ratini S; Del Castillo A; Colleoni M; Talakhadze N; Rotmensz N; Viale G; Veronesi U; Luini A
    Ann Surg Oncol; 2011 Oct; 18(10):2879-84. PubMed ID: 21479691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocal and multicentric breast cancer: does each focus matter?
    Coombs NJ; Boyages J
    J Clin Oncol; 2005 Oct; 23(30):7497-502. PubMed ID: 16234516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary lymph node status and prognosis in multifocal and multicentric breast carcinoma.
    Duraker N; Caynak ZC
    Breast J; 2014; 20(1):61-8. PubMed ID: 24438065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma.
    Andea AA; Bouwman D; Wallis T; Visscher DW
    Cancer; 2004 Jan; 100(1):20-7. PubMed ID: 14692020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal breast cancer in women < or =35 years old.
    Litton JK; Eralp Y; Gonzalez-Angulo AM; Broglio K; Uyei A; Hortobagyi GN; Arun B
    Cancer; 2007 Oct; 110(7):1445-50. PubMed ID: 17676585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
    Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Axillary skip metastases in breast cancer].
    Sun JY; Ning LS
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):352-5. PubMed ID: 18953834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
    Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
    Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.